Puff Puff Post

MARCH 2, 2020

NEWS FROM KHIRON LIFE SCIENCES CORP. · Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority (“TQG”) allows the Company to now produce oils for sale both domestically and abroad. · Of the 9.3

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

NOVEMBER 10, 2021

Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. for its MET for the nasal delivery of cannabidiol (CBD) for the management of epilepsy in children (rare pediatric disease) and adults. Operating Expenses.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Otherside Farms

FEBRUARY 14, 2019

billion by 2020; the World Anti-Doping Agency eliminated the CBD from its list of banned substances; The Food and Drug Administration (FDA) for the first time approved a drug for epilepsy that contained CBD oil, prompting the US Drug Enforcement Administration to change its position about the CBD. What is CBD?

CBD 65

CBD Legalization Hemp Chronic Pain 65

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

JANUARY 1, 2020

Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain. National legalisation of medical cannabis could occur as early as 2020 in Spain. Acceptance of Medicinal Cannabis.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Puff Puff Post

JANUARY 1, 2020

Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain. National legalisation of medical cannabis could occur as early as 2020 in Spain. Acceptance of Medicinal Cannabis.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

OCTOBER 26, 2021

Dr. Chapman is a graduate of the Harvard Kennedy School, Cambridge, Massachusetts, in financial management (2020). The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. 1 Data published by Research and Markets, March 2018. About the Arthritis Foundation.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 17, 2020

As such, I am representative of the face of medical marijuana in Florida , one of 311,266 qualified active patients with ID cards as of February 7, 2020. Marijuana Statistics 2019, Usage, Trends and Data). Even my doctors and specialists are amazed at my progress! STATE OF FLORIDA. Amyotrophic Lateral Sclerosis (ALS). Crohn’s Disease.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

NOVEMBER 22, 2019

The state expects to issue its first license by the end of November and sales to begin by the end of the first quarter 2020. South Dakota activists turned in what should be more than enough signatures to qualify separate cannabis legalization and medical cannabis initiatives for the state’s 2020 ballot.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40